Skip to product information
1 of 1

Rinzimetostat (TFA)

Rinzimetostat (TFA)

Size

SKU:QM-0152475-01

£362.25 GBP
Sale Sold out
Quantity

Request quote or documents

View full details
  • Description

    Rinzimetostat (ORIC-944) TFA is the TFA salt form of ORIC. Rinzimetostat TFA is a selective, orally active, allosteric inhibitor targeting the EED subunit of polycomb repressive complex 2 (PRC2). Rinzimetostat TFA is synergistic with androgen receptor pathway inhibitors (ARPIs) for the study of metastatic prostate cancer[1][2].

  • Molecular Formula

    C28H26F4N6O3

  • Molecular Weight

    570.54

  • Smiles

    CC1=C(C=CC(CN(C)C)=C1)C2=CN=C(N3C=C(N=C23)C#N)NCC4=C(C=CC5=C4CCO5)F.O=C(C(F)(F)F)O

  • Target

    Histone Methyltransferase

  • Purity

    98.87

  • Solubility

    DMSO : 50 mg/mL (ultrasonic)

  • Storage Conditions

    4°C (Powder, sealed storage, away from moisture)

  • Shipping Conditions

    Room Temperature

Your cart
Variant Variant total Quantity Price Variant total
5 mgQM-0152475-01
5 mgQM-0152475-01
Regular price
£231.30
Sale price
£362.25/ea
£0.00
Regular price
£231.30
Sale price
£362.25/ea
£0.00
10 mgQM-0152475-02
10 mgQM-0152475-02
Regular price
£370.80
Sale price
£550.58/ea
£0.00
Regular price
£370.80
Sale price
£550.58/ea
£0.00

View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

Rinzimetostat (TFA)

Rinzimetostat (TFA) is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.